documents: FDA-2026-N-4573-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-4573-0001 FDA FDA-2026-N-4573 Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AVLAYAH (tividenofusp alfa-eknm) Notice Announcement 2026-05-11T04:00:00Z 2026 5 2026-05-11T04:00:00Z   2026-05-11T17:34:15Z 2026-09242 0 0 09000064b92cf987

Links from other tables